Advisory Commission on Childhood Vaccines; Notice of Meeting, 6781 [E6-1733]

Download as PDF Federal Register / Vol. 71, No. 27 / Thursday, February 9, 2006 / Notices V. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES), written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Comments received may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: February 1, 2006. Linda S. Kahan, Deputy Director, Center for Devices and Radiological Health. [FR Doc. E6–1787 Filed 2–8–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting cprice-sewell on PROD1PC66 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 9, 2006, 9 a.m.–3:30 p.m., EST. Place: Audio Conference Call and Parklawn Building, Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, March 9, from 9 a.m. to 3:30 p.m. The public can join the meeting in person at the address listed above or by audio conference call by dialing 1–800–369–6048 on March 9 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the March meeting will include, but are not limited to: An overview of compensation programs in other countries; results of the National Vaccine Injury Compensation Program’s (VICP) Program Assessment Rating Tool; a discussion of the Division of Vaccine Injury Compensation’s (DVIC) communication strategies; a report from the ACCV Workgroup looking at proposed guidelines for future changes to the Vaccine Injury Table; and updates from DVIC, Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases VerDate Aug<31>2005 16:34 Feb 08, 2006 Jkt 208001 (National Institutes of Health), and Center for Biologics and Evaluation Research (Food and Drug Administration). Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Ms. Cheryl Lee, Principal Staff Liaison, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail clee@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff Liaison, DVIC, HSB, HRSA, Room 11C– 26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–2124 or e-mail clee@hrsa.gov. Dated: February 2, 2006. Tina M. Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. E6–1733 Filed 2–8–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Privacy Act System of Records Notice 09–17–0001, ‘‘Medical, Health and Billing Records’’: Correction AGENCY: Indian Health Service (IHS), HHS. ACTION: Notice: correction. SUMMARY: The Indian Health Service published a document in the Federal Register on December 30, 2005. The document contained an error. FOR FURTHER INFORMATION CONTACT: Contact Ms. Patricia Gowan, IHS Lead Health Information Management (HIM) Consultant (Acting), Office of Health Programs, Phoenix Area Office IHS, Two Renaissance Square, Suite 606, 40 North Central Avenue, Phoenix, AZ PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 6781 85004 or via the Internet at Patricia.Gowan@ihs.gov. Correction In the Federal Register of December 30, 2005, in FR Doc 05–24644, on page 77407, in the second column, correct number 5 to read: ‘‘Records may be disclosed to the Bureau of Indian Affairs (BIA) or its contractors under an agreement between IHS and the BIA relating to disabled AI/AN children for the purposes of carrying out its functions under the Individuals with Disabilities Education Act (IDEAS), 20 U.S.C. 1400, et seq.’’ Re-number 5 to number 6 and so forth for a total of twenty-four routine uses instead of twenty-three. Dated: February 2, 2006. Robert G. McSwain, Deputy Director, Indian Health Service. [FR Doc. 06–1188 Filed 2–8–06; 8:45 am] BILLING CODE 4165–16–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Inspector General Program Exclusions: January 2006 AGENCY: Office of Inspector General, HHS. ACTION: Notice of program exclusions. During the month of January 2006, the HHS Office of Inspector General imposed exclusions in the cases set forth below. When an exclusion is imposed, no program payment is made to anyone for any items or services (other than an emergency item or service not provided in a hospital emergency room) furnished, ordered or prescribed by an excluded party under the Medicare, Medicaid, and all Federal Health Care programs. In addition, no program payment is made to any business or facility, e.g., a hospital, that submits bills for payment for items or services provided by an excluded party. Program beneficiaries remain free to decide for themselves whether they will continue to use the services of an excluded party even though no program payments will be made for items and services provided by that excluded party. The exclusions have national effect and also apply to all Executive Branch procurement and nonprocurement programs and activities. E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 71, Number 27 (Thursday, February 9, 2006)]
[Notices]
[Page 6781]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: March 9, 2006, 9 a.m.-3:30 p.m., EST.
    Place: Audio Conference Call and Parklawn Building, Conference 
Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, March 9, from 9 a.m. to 3:30 
p.m. The public can join the meeting in person at the address listed 
above or by audio conference call by dialing 1-800-369-6048 on March 
9 and providing the following information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the March meeting will include, but 
are not limited to: An overview of compensation programs in other 
countries; results of the National Vaccine Injury Compensation 
Program's (VICP) Program Assessment Rating Tool; a discussion of the 
Division of Vaccine Injury Compensation's (DVIC) communication 
strategies; a report from the ACCV Workgroup looking at proposed 
guidelines for future changes to the Vaccine Injury Table; and 
updates from DVIC, Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics and 
Evaluation Research (Food and Drug Administration). Agenda items are 
subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Ms. Cheryl Lee, Principal Staff Liaison, 
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services 
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, 
Maryland 20857 or e-mail clee@hrsa.gov. Requests should contain the 
name, address, telephone number, and any business or professional 
affiliation of the person desiring to make an oral presentation. 
Groups having similar interests are requested to combine their 
comments and present them through a single representative. The 
allocation of time may be adjusted to accommodate the level of 
expressed interest. DVIC will notify each presenter by mail or 
telephone of their assigned presentation time. Persons who do not 
file an advance request for a presentation, but desire to make an 
oral statement, may announce it at the time of the comment period. 
These persons will be allocated time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff 
Liaison, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, 
MD 20857; telephone (301) 443-2124 or e-mail clee@hrsa.gov.

    Dated: February 2, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
 [FR Doc. E6-1733 Filed 2-8-06; 8:45 am]
BILLING CODE 4165-15-P